133
0 Kommentare
Microbix Presenting at Florida Capital Event Conference - Seite 2
Microbix also applies its biological expertise and infrastructure to develop other proprietary products and technologies, most notably Kinlytic urokinase, a biologic drug used to dissolve blood clots, and viral transport medium (DxTM) used to stabilize patient samples for lab-based molecular diagnostic testing. Microbix is traded on the TSX and OTCQX, and headquartered in Mississauga, Ontario, Canada.
About Capital Event Management Ltd. and the Event
Capital Event Management Ltd. produces multiple investor events each year, across North America, on Bermuda, and in the Bahamas. Attendees include leading public and private companies, and a range
of investors consisting of investment advisors, fund managers, and high net worth investors. Capital Event’s unique event formats aim to allow principals to establish new and lasting relationships
that lead to financings, open market support, and increased awareness within the investment community. Further information about the Florida event is available at https://cem.ca/conference/florida-capital-event-2023/
Lesen Sie auch
Forward-Looking Information
This news release includes “forward-looking information,” as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, discussion of Capital
Event Management Ltd. and its conferences, Microbix’s business and business results, goals or outlook, risks associated with financial results and stability, development projects such as those
referenced in its corporate presentation or verbal comments, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness
of delivery), foreign currency and exchange rates, maintaining profitability and adequate working capital, or raising further capital on acceptable terms or at all, and other similar statements
concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are
not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain, and that actual performance may be affected by many material factors, some
of which are beyond the Company’s control. Accordingly, actual future events, conditions, and results may differ materially from the estimates, beliefs, intentions, and expectations expressed or
implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this new release, and the Company is
under no obligation to update or alter any forward-looking information.